Caring Brands (CABR) Revenue (2024 - 2025)

Caring Brands' (CABR) quarterly Revenue came in at $1586.0 in Q4 2025, up 241.08% year-on-year from $465.0 in Q4 2024, and up 114.32% quarter-over-quarter from $740.0 in Q3 2025.

Caring Brands (CABR) Revenue (2024 - 2025) Analysis & Trends

Caring Brands' Revenue history runs 2 years deep, the most recent figure standing at $1586.0 for Q4 2025.

  • On a quarterly basis, Revenue rose 241.08% year-over-year to $1586.0 in Q4 2025; TTM through Dec 2025 was $4260.0, a N/A change from a year earlier, with the FY2025 full-year figure at $4215.0, changed N/A from the prior year.
  • Revenue improved to $1586.0 in Q4 2025 per CABR's latest filing, from $740.0 in the prior quarter.
  • Across five years, Revenue topped out at $1586.0 in Q4 2025 and bottomed at $465.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn 3.98 Bn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 2.26 Bn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn 6.98 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 781.50 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn 3.51 Bn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 814.50 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn 1.37 Bn
10 Caring Brands 20.66 Mn 18.63 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 1,586.00
Sep 30, 2025 740.00
Mar 31, 2025 1,469.00
Dec 31, 2024 465.00